Hepatitis C News

Onsite screening with a fingerstick assay at addiction treatment centers increased diagnosis and treatment of hepatitis C among people who use drugs, researchers reported.

Game-changing therapies have made the WHO goal of achieving hepatitis C elimination by 2030 possible, but many countries find themselves fighting an uphill battle, according to experts.

Hepatitis C testing has increased in recent years among people who are incarcerated in provincial correctional centers in British Columbia, Canada, according to new data.

New data suggest that failure to achieve sustained virologic response after treatment with direct-acting antivirals for hepatitis C was a strong predictor for development of hepatocellular carcinoma.

Patients with hepatitis C virus have always carried an increased risk for developing hepatocellular carcinoma. Although antiviral treatment for HCV reduces that risk, it is not eliminated.

The prevalence of hepatitis C infections has declined globally, but countries must scale up rates of diagnosis and treatment to achieve the WHO targets to eliminate HCV by 2030, according to new data.

Healio spoke with Nancy S. Reau, MD, FAASLD, AGAF, about results from a study examining maternal and childhood outcomes of hepatitis C presented at The Liver Meeting Digital Experience.

In this video, Nancy S. Reau, MD, FAASLD, AGAF, discussed one of the themes from The Liver Meeting Digital Experience: the effect of the COVID-19 pandemic on hepatitis C care.

Healio spoke with Nancy S. Reau, MD, FAASLD, AGAF, about a study evaluating a hepatitis C retreatment regimen in patients who failed therapy with Vosevi.

In this video, Nancy S. Reau, MD, FAASLD, AGAF, discussed a study presented at The Liver Meeting Digital Experience demonstrating the effectiveness of a rapid treatment model in engaging people who inject drugs in treating their hepatitis C virus.